ArticleJCO global oncology2022

NOHA: A Promising Biomarker for Determining Estrogen Receptor Status Among Patients With Breast Cancer in Resource-Constrained Settings.

Furaha Serventi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.